Head-to-head · WeighScore
Revel Health vs Rixa Health
The verdict
Revel Health takes it — 66.2/100 to 60.5/100.
Revel Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Revel Health is a telehealth platform combining GLP-1 weight loss with longevity care — semaglutide and tirzepatide plus NAD+, sermorelin and peptide therapy — prescribed by board-certified physicians and…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Revel Health | Rixa Health |
|---|---|---|
| WeighScore | 66.2/100 | 60.5/100 |
| Grade | C | C |
| Scorecard rank | #197 | #320 |
| Semaglutide | $199/mo (compounded) | Not disclosed |
| Tirzepatide | $249/mo (starting dose, compounded) | Not disclosed |
| Coverage | 45 states | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Graded #197 · C
Strengths
- LegitScript certified with board-certified physicians and USP 795/800 compounding
- Combines GLP-1 weight loss with NAD+, sermorelin and longevity care
- Fast intake — a physician reviews within the hour
- Available in 45 states with a clear list of where it operates
Where it loses points
- Doesn't show upfront pricing — you learn cost during checkout
- Not available in AK, AR, NC, NJ or MS
- Compounded medications only — no brand-name options noted
- Longevity add-ons add cost beyond the core GLP-1 program
Graded #320 · C
Strengths
- Functional-medicine, root-cause clinical approach
- Compounded and oral semaglutide plus tirzepatide offered
- Board-certified DO and FNP providers with years of experience
- Medication bundled with visits into a single price
- No charge until after approval
Where it loses points
- No public monthly pricing; quoted only during consultation
- Relies on compounded GLP-1, which is not FDA-approved as a finished drug
- A handful of states still listed as coming soon
- Branded GLP-1 medications are not the primary offering
- Requires ongoing monthly follow-up commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.